TY - JOUR
T1 - Ageing in individuals with intellectual disability
T2 - Issues and concerns in Hong Kong
AU - Tse, Mimi M.Y.
AU - Kwan, Rick Y.C.
AU - Lau, Joyce L.
N1 - Publisher Copyright:
© 2018, Hong Kong Academy of Medicine Press. All rights reserved.
PY - 2018/2
Y1 - 2018/2
N2 - Introduction: The increasing longevity of people with intellectual disability is testimony to the positive developments occurring in medical intervention. Nonetheless, early-onset age-related issues and concerns cause deterioration of their overall well-being. This paper aimed to explore the issues and concerns about individuals with intellectual disability as they age. Methods: Articles that discussed people older than 30 years with an intellectual disability and those that identified ageing health issues and concerns were included. Only studies reported in English from 1996 to 2016 were included. We searched PubMed, Google Scholar, and Science Direct using the terms ‘intellectual disability’, ‘ageing’, ‘cognitive impairment’, ‘health’, and ‘screening’. Results: Apart from the early onset of age-related health problems, dementia is more likely to develop by the age of 40 years in individuals with intellectual disability. Geriatric services to people with intellectual disability, however, are only available for those aged 60 years and older. Cognitive instruments used for the general population are not suitable for people with intellectual disability because of floor effects. In Hong Kong, the Chinese version of the Dementia Screening Questionnaire for Individuals with Intellectual Disabilities is the only validated instrument for people with intellectual disability. The use of appropriate measurement tools to monitor the progression of age-related conditions in individuals with intellectual disability is of great value. Conclusions: Longitudinal assessment of cognition and function in people with intellectual disability is vital to enable early detection of significant deterioration. This allows for therapeutic intervention before substantial damage to the brain occurs such as dementia that hastens cognitive and functional decline.
AB - Introduction: The increasing longevity of people with intellectual disability is testimony to the positive developments occurring in medical intervention. Nonetheless, early-onset age-related issues and concerns cause deterioration of their overall well-being. This paper aimed to explore the issues and concerns about individuals with intellectual disability as they age. Methods: Articles that discussed people older than 30 years with an intellectual disability and those that identified ageing health issues and concerns were included. Only studies reported in English from 1996 to 2016 were included. We searched PubMed, Google Scholar, and Science Direct using the terms ‘intellectual disability’, ‘ageing’, ‘cognitive impairment’, ‘health’, and ‘screening’. Results: Apart from the early onset of age-related health problems, dementia is more likely to develop by the age of 40 years in individuals with intellectual disability. Geriatric services to people with intellectual disability, however, are only available for those aged 60 years and older. Cognitive instruments used for the general population are not suitable for people with intellectual disability because of floor effects. In Hong Kong, the Chinese version of the Dementia Screening Questionnaire for Individuals with Intellectual Disabilities is the only validated instrument for people with intellectual disability. The use of appropriate measurement tools to monitor the progression of age-related conditions in individuals with intellectual disability is of great value. Conclusions: Longitudinal assessment of cognition and function in people with intellectual disability is vital to enable early detection of significant deterioration. This allows for therapeutic intervention before substantial damage to the brain occurs such as dementia that hastens cognitive and functional decline.
UR - http://www.scopus.com/inward/record.url?scp=85041504013&partnerID=8YFLogxK
U2 - 10.12809/hkmj166302
DO - 10.12809/hkmj166302
M3 - Review article
C2 - 29326402
AN - SCOPUS:85041504013
SN - 1024-2708
VL - 24
SP - 68
EP - 72
JO - Hong Kong Medical Journal
JF - Hong Kong Medical Journal
IS - 1
ER -